Burlington, Massachusetts, February 4, 2021 — Building on its commitment to accelerate scientific research and science education, MilliporeSigma has announced seven expanded partnerships with leading nonprofit organizations across the world. These long-term, multi-dimensional partnerships are designed to increase educational and research equity supporting UN Sustainable Development Goal 4, Quality Education — giving students, researchers and teachers the tools they need to spark curiosity in science and pave the road to a future of innovation.
“As 2020 has demonstrated, the world needs the full contribution of our population, which means a diverse, inclusive and equitable representation in the sciences,” said Renee Connolly, head of global communication at MilliporeSigma. “Our commitment to bring this to bear is not new, but it is now clearer and more intentional in impact and outcomes.”
To support today’s scientists, MilliporeSigma continues to support the below organizations geared toward scientific research.
To spark curiosity and increase opportunities for the next generation of scientists, MilliporeSigma continues to focus on signature partnerships that advance science education.
For more information about MilliporeSigma’s employee and community engagement initiatives, visit the Sustainability and Social Innovation page.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has some 22,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck KGaA, Darmstadt, Germany generated sales of €16.2 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.